{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-017192","form_type":"8-K","ticker":"AMWL","cik":"0001393584","company_name":"American Well Corp","filed_at":"2023-05-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.681293+00:00","generated_at":"2026-06-16T00:43:29.828207+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Amwell Q1 revenue $64M; net loss $398.5M with $330.3M goodwill impairment","bullets":["Revenue $64.0M (subscription $28.7M, AMG visits $32.5M); gross margin 39.5%.","Net loss ($398.5M) vs ($61.6M) in Q4 2022; includes $330.3M non-cash goodwill impairment.","Adjusted EBITDA ($44.6M) vs ($43.4M) in prior quarter.","Total visits 1.7M; Converge platform visits grew to 36% of total (from 28% in Q4 2022).","FY 2023 guidance reaffirmed: revenue $275-285M, Adj. EBITDA ($150M)-($160M)."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-017192","json":"https://secwatch.observer/filing/0000950170-23-017192.json","markdown":"https://secwatch.observer/filing/0000950170-23-017192.md","text":"https://secwatch.observer/filing/0000950170-23-017192.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1393584/000095017023017192/0000950170-23-017192-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1393584/000095017023017192/amwl-20230503.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-16T00:43:29.828207+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"be79a2f33d16007938ca363559acfa01a716eefe","claim":"American Well Corp reported first quarter ended March 31, 2023 results: revenue $64.0 million, net income ($398.5) million. Guidance reaffirmed.","evidence_excerpt":"in digital healthcare enablement, today announced financial results for the first quarter ended March 31, 2023. Amwell First Quarter 2023 Highlights: • Recorded Total Revenue of $64.0 million o Achieved subscription revenue of $28.7 million o Recorded AMG Visit revenue of $32.5 million • Reported gross margin of 39.5% • Net loss was ($398.5) million, compared to","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1393584/000095017023017192/0000950170-23-017192-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter ended March 31, 2023"},{"label":"Revenue","value":"$64.0 million"},{"label":"Net income","value":"($398.5) million"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}